A PMMA bone cement composite that functions as a drug-refillable depot for localized, multi-window chemotherapeutic treatment of bone cancer
Preprint
Abstract
Standard chemotherapy for primary and secondary bone tumors typically involves systemic administration of chemotherapeutic drugs, such as doxorubicin (DOX). However, non-targeted delivery increases dose requirements, and results in off-target toxicity and suboptimal chemotherapeutic efficacy. When chemotherapy is ineffective, substantial resection of tissue and/or total amputation become necessary – a debilitating outcome for any patient. In this work, we developed a proof-of-concept, non-biodegradable, mechanically robust, and refillable composite system for chemotherapeutic (i.e. DOX) delivery comprised of poly(methyl methacrylate) (PMMA) bone cement and insoluble polymeric γ-cyclodextrin (γ-CD) microparticles. The porosity and compressive strength of DOX-filled PMMA composites were characterized. DOX filling capacity, elution kinetics, cytotoxicity against primary osteosarcoma and lung cancer cells, and refilling capacity of composites were evaluated. PMMA composites containing up to 15wt% γ-CD microparticles provided consistent, therapeutically-relevant release of DOX with ~100% of the initial DOX released after 100 days. Over the same period, only ~6% of DOX was liberated from PMMA with free DOX. Following prolonged curing, PMMA composites with up to 15wt% γ-CD surpassed compressive strength requirements outlined by international standards for acrylic bone cements. Compared to DOX-filled PMMA, DOX-filled PMMA/γ-CD composites provided long-term release with decreased burst effect, correlating to long-term cytotoxicity against cancer cells. Refillable properties demonstrated by the PMMA composite system may find utility for treating local recurrences, limiting chemoresistance, and altering drug combinations to provide customized treatment regimens. Overall, findings suggest that PMMA composites have the potential to serve as a platform for the delivery of combinatorial chemotherapeutics to treat bone tumors.Keywords
All Related Versions
- Published version: Macromolecular Bioscience, 22 (5), 2100415.
This publication has 66 references indexed in Scilit:
- Renal and Hepatic Toxicities After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)Annals of Surgical Oncology, 2013
- HMGB1 Promotes Drug Resistance in OsteosarcomaCancer Research, 2012
- Affinity‐Based Drug DeliveryMacromolecular Bioscience, 2010
- Cyclodextrin Complexation for Affinity‐Based Antibiotic DeliveryMacromolecular Bioscience, 2009
- The Compressive Properties of Bone Cements Containing Large Doses of AntibioticsThe Journal of Arthroplasty, 2009
- Quantitative analysis of the effect of porosity on the fatigue strength of bone cementActa Biomaterialia, 2009
- Method for the Physical Analysis of Drug-bone Cement CompositeClinical Orthopaedics and Related Research, 2007
- Isolated lung perfusion with doxorubicin reduces cardiac and host toxicities associated with systemic administrationThe Annals of Thoracic Surgery, 1996
- Cisplatin-loaded poly (methyl methacrylate) implants: a sustained drug delivery systemJournal of Controlled Release, 1995
- Preparation and characterization of cisplatin-loaded polymethyl methacrylate microspheresInternational Journal of Pharmaceutics, 1993